We are live on
!
Find out more
TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
109 hedge funds and large institutions have $500M invested in Taro Pharmaceutical Industries Ltd. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
32% more call options, than puts
Call options by funds: $336K | Put options by funds: $255K
13% more capital invested
Capital invested by funds: $442M → $500M (+$58M)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0% more funds holding
Funds holding: 109 → 109 (0)
40% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 45
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
109
Holders Change
–
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
14
Increased
27
Reduced
45
Closed
13
Calls
$336K
Puts
$255K
Net Calls
+$81K
Net Calls Change
+$108K
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$20.3M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$15M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$3.64M |
| 4 |
Morgan Stanley
New York
|
+$3.45M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.21M |
